Caxton Associates (New York)’s Perspecta Inc. Common Stock PRSP Stock Holding History

Caxton Associates (New York)’s Portfolio PRSP Stock Details PRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,617	Closed	-$599K	–	666
2021 Q1	$599K	Buy	+20,617	New	+$581K	0.05%	135
2020 Q1	–	Sell	-7,591	Closed	-$201K	–	649
2019 Q4	$201K	Buy	+7,591	New	+$202K	0.03%	358
2018 Q4	–	Sell	-34,177	Closed	-$879K	–	519
2018 Q3	$879K	Sell	34,177 -24,273	-42%	-$566K	0.06%	158
2018 Q2	$1.2M	Buy	+58,450	New	+$1.31M	0.06%	149

Other funds holding PRSP

Kellner Capital New York $55.5M AUM 88.05% 1-Year Est. Return

EBSAM

Eubel Brady & Suttman Asset Management Miamisburg, Ohio $842M AUM 17.25% 1-Year Est. Return

Caxton Associates (New York)'s PRSP Position: Q2 2021 in Review

Caxton Associates (New York) sold out of Perspecta Inc. Common Stock (PRSP) in Q2 2021, closing a stake of 20,617 shares — an estimated $599K sold.

Caxton Associates (New York) first reported a position in PRSP in Q2 2018 and held it in 4 quarters. The position peaked at $1.2M in Q2 2018. 2 funds tracked by Wall St. Rank hold PRSP as of Q2 2021.

Caxton Associates (New York) reported no remaining Perspecta Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Caxton Associates (New York) sold 20,617 Perspecta Inc. Common Stock shares in Q2 2021, an estimated $599K.
Caxton Associates (New York) first reported a position in Perspecta Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Caxton Associates (New York)'s Perspecta Inc. Common Stock position peaked at $1.2M in Q2 2018.
2 funds tracked by Wall St. Rank held Perspecta Inc. Common Stock as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.